- Home
- SPRY vs SDHC Comparison
SPRY vs SDHC Comparison
Compare SPRY & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- SDHC
- Stock Information
- Founded
- SPRY 2015
- SDHC 2008
- Country
- SPRY United States
- SDHC United States
- Employees
- SPRY N/A
- SDHC N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- SDHC
- Sector
- SPRY Health Care
- SDHC
- Exchange
- SPRY Nasdaq
- SDHC Nasdaq
- Market Cap
- SPRY 1.1B
- SDHC 1.3B
- IPO Year
- SPRY N/A
- SDHC 2024
- Fundamental
- Price
- SPRY $11.24
- SDHC $23.67
- Analyst Decision
- SPRY Strong Buy
- SDHC Hold
- Analyst Count
- SPRY 4
- SDHC 5
- Target Price
- SPRY $26.00
- SDHC $29.60
- AVG Volume (30 Days)
- SPRY 1.2M
- SDHC 75.1K
- Earning Date
- SPRY 03-20-2025
- SDHC 03-12-2025
- Dividend Yield
- SPRY N/A
- SDHC N/A
- EPS Growth
- SPRY N/A
- SDHC N/A
- EPS
- SPRY N/A
- SDHC 4.71
- Revenue
- SPRY $2,568,000.00
- SDHC $905,304,000.00
- Revenue This Year
- SPRY $68,783.34
- SDHC $27.24
- Revenue Next Year
- SPRY $503.87
- SDHC $9.97
- P/E Ratio
- SPRY N/A
- SDHC $5.02
- Revenue Growth
- SPRY 8460.00
- SDHC 17.46
- 52 Week Low
- SPRY $7.55
- SDHC $20.55
- 52 Week High
- SPRY $18.51
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- SPRY 37.72
- SDHC 45.89
- Support Level
- SPRY $11.58
- SDHC $22.75
- Resistance Level
- SPRY $12.43
- SDHC $24.10
- Average True Range (ATR)
- SPRY 0.72
- SDHC 0.98
- MACD
- SPRY -0.14
- SDHC 0.20
- Stochastic Oscillator
- SPRY 0.53
- SDHC 54.43
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. The company has organized into five geographical segments so their reportable segments include Atlanta, Raleigh, Charlotte, Nashville, and Alabama which consists of both Birmingham and Huntsville.